This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ ioxaglic acid,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Enhancement of Imaging: The primary purpose of ioxaglic acid is to improve the visibility of structures and organs during diagnostic imaging procedures. It works by altering the density of the tissues it flows through, making them more visible on X-ray or CT images. This enhancement allows healthcare providers to obtain clearer and more detailed images for the diagnosis and management of various medical conditions.

  2. Intravenous Administration: Ioxaglic acid is typically administered intravenously, meaning it is injected directly into a vein. The dose and rate of administration depend on the specific imaging procedure being performed, the patient's age, weight, and medical history, as well as the imaging equipment being used. Healthcare providers carefully monitor patients during and after the injection to ensure safety and optimal imaging results.

  3. Adverse Reactions: Like other contrast agents, ioxaglic acid carries the risk of causing adverse reactions in some patients. Common side effects may include warmth or flushing sensation at the injection site, mild nausea, vomiting, headache, dizziness, and a metallic taste in the mouth. These reactions are usually mild and temporary, resolving on their own without medical intervention.

  4. Allergic Reactions: In rare cases, some individuals may experience allergic reactions to ioxaglic acid. These reactions can range from mild to severe and may include itching, hives, rash, difficulty breathing, wheezing, swelling of the face, lips, tongue, or throat (angioedema), and anaphylaxis (a life-threatening allergic reaction). Patients with a history of allergies, asthma, or previous reactions to contrast agents should inform their healthcare provider before undergoing imaging procedures with ioxaglic acid.

  5. Renal Toxicity: Contrast-induced nephropathy (CIN) is a potential complication associated with the use of contrast agents like ioxaglic acid. CIN refers to a temporary decrease in kidney function that occurs after the administration of contrast media. It is more common in patients with pre-existing kidney disease, diabetes, dehydration, or other risk factors. Healthcare providers may take precautions to minimize the risk of CIN in high-risk patients, such as ensuring adequate hydration and using the lowest possible dose of contrast agent.

  6. Contraindications: Ioxaglic acid is contraindicated in patients with a known allergy to the drug or its components, as well as in patients with severe kidney impairment or acute renal failure. It should be used with caution in patients with a history of allergic reactions to other contrast agents, asthma, heart disease, or thyroid disorders.

;

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

Data Contradictions — Limits of Certainity

Impacted of ioxaglic acid,(prescription) On Probiotics

Rank Probiotic Impact
species Anaerobutyricum hallii Reduces
species Bacteroides uniformis Reduces
species Blautia wexlerae Reduces
species Christensenella minuta Reduces
species Escherichia coli Reduces
species Lactococcus cremoris Reduces

Bacteria Impacted by ioxaglic acid,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 Phocaeicola genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Agathobacter genus Decreases
0 1 Odoribacter genus Decreases
0 1 Bilophila genus Decreases
0 1 Enterocloster genus Decreases
0 1 Escherichia genus Decreases
0 1 Segatella genus Decreases
0 1 Bacteroides genus Decreases
0 1 Fusobacterium genus Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
1 0 [Ruminococcus] torques species Decreases
1 0 Phocaeicola vulgatus species Decreases
1 0 Agathobacter rectalis species Decreases
1 0 Odoribacter splanchnicus species Decreases
1 0 Bilophila wadsworthia species Decreases
0 1 Dorea formicigenerans species Decreases
0 1 Coprococcus catus species Decreases
0 1 Dorea longicatena species Decreases
0 1 Blautia obeum species Decreases
0 1 Anaerobutyricum hallii species Decreases
1 0 Enterocloster bolteae species Decreases
0 1 Blautia sp. SC05B48 species Decreases
0 1 Ligilactobacillus ruminis species Decreases
1 0 Escherichia coli species Decreases
0 1 Bacillus paralicheniformis species Decreases
0 1 Eubacterium ventriosum species Decreases
0 1 [Ruminococcus] lactaris species Decreases
0 1 Wansuia hejianensis species Decreases
0 1 Komagataeibacter oboediens species Decreases
0 1 Butyrivibrio crossotus species Decreases
0 1 Subdoligranulum variabile species Decreases
0 1 Faecalibacillus intestinalis species Decreases
1 0 Segatella copri species Decreases
0 1 Blautia liquoris species Decreases
0 1 Clostridium sp. SY8519 species Decreases
0 1 uncultured Alistipes sp. species Decreases
0 1 Lachnoanaerobaculum gingivalis species Decreases
0 1 Anaerostipes hadrus species Decreases
0 1 Coprococcus comes species Decreases
0 1 Intestinibaculum porci species Decreases
0 1 Massilistercora timonensis species Decreases
0 1 Faecalitalea cylindroides species Decreases
0 1 Lacrimispora saccharolytica species Decreases
0 1 Faecalibacterium sp. IP-3-29 species Decreases
0 1 Faecalibacterium duncaniae species Decreases
0 1 Catenibacterium sp. co_0103 species Decreases
0 1 Novisyntrophococcus fermenticellae species Decreases
0 1 Clostridium sp. M62/1 species Decreases
1 0 Bacteroides fragilis species Decreases
0 1 Catenibacterium mitsuokai species Decreases
0 1 Qiania dongpingensis species Decreases
0 1 Alistipes ihumii species Decreases
0 1 Christensenella minuta species Decreases
0 1 Pseudobutyrivibrio xylanivorans species Decreases
0 1 Faecalibacterium sp. I2-3-92 species Decreases
0 1 Longicatena caecimuris species Decreases
0 1 Roseburia rectibacter species Decreases
0 1 Faecalibacterium sp. I3-3-89 species Decreases
0 1 Faecalibacterium sp. I3-3-33 species Decreases
0 1 [Clostridium] hylemonae species Decreases
0 1 Treponema peruense species Decreases
0 1 Eubacterium sp. MSJ-33 species Decreases
0 1 Maliibacterium massiliense species Decreases
0 1 Coprococcus eutactus species Decreases
0 1 Coprobacter secundus species Decreases
0 1 Marvinbryantia formatexigens species Decreases
0 1 Alistipes communis species Decreases
0 1 Alistipes dispar species Decreases
0 1 Alistipes shahii species Decreases
0 1 Ruminococcus champanellensis species Decreases
0 1 Blautia wexlerae species Decreases
0 1 Alistipes megaguti species Decreases
0 1 Alistipes senegalensis species Decreases
0 1 Roseburia intestinalis species Decreases
0 1 Lachnoclostridium phocaeense species Decreases
0 1 Lactococcus cremoris species Decreases
0 1 Adlercreutzia equolifaciens species Decreases
0 1 Clostridium cadaveris species Decreases
0 1 Wujia chipingensis species Decreases
0 1 Ruminococcus gauvreauii species Decreases
0 1 Faecalibacterium sp. I4-1-79 species Decreases
0 1 Coprococcus sp. ART55/1 species Decreases
0 1 Romboutsia ilealis species Decreases
0 1 Butyricimonas virosa species Decreases
0 1 Enterococcus cecorum species Decreases
0 1 Streptococcus suis species Decreases
0 1 Alistipes sp. dk3624 species Decreases
0 1 Faecalibaculum rodentium species Decreases
0 1 Coprobacter fastidiosus species Decreases
0 1 Faecalibacterium sp. I4-3-84 species Decreases
0 1 Phascolarctobacterium sp. Marseille-Q4147 species Decreases
0 1 Vescimonas fastidiosa species Decreases
0 1 Roseburia hominis species Decreases
0 1 [Eubacterium] hominis species Decreases
0 1 Monoglobus pectinilyticus species Decreases
0 1 Shigella dysenteriae species Decreases
0 1 Faecalibacterium sp. HTF-F species Decreases
0 1 Phascolarctobacterium succinatutens species Decreases
0 1 Solibaculum mannosilyticum species Decreases
0 1 Mogibacterium diversum species Decreases
0 1 Parvimonas micra species Decreases
0 1 Mageeibacillus indolicus species Decreases
0 1 Shigella flexneri species Decreases
0 1 Faecalibacterium sp. IP-1-18 species Decreases
0 1 Treponema denticola species Decreases
0 1 Escherichia albertii species Decreases
0 1 Ruminococcus bicirculans (ex Wegman et al. 2014) species Decreases
0 1 Simiaoa sunii species Decreases
0 1 Actinomyces oris species Decreases
0 1 Oscillibacter hominis species Decreases
1 0 Bacteroides uniformis species Decreases
1 0 Fusobacterium nucleatum species Decreases
0 1 Fusobacterium nucleatum subsp. nucleatum subspecies Decreases

Impact of ioxaglic acid,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.2 0.2
ADHD 0.7 0.4 0.75
Age-Related Macular Degeneration and Glaucoma 0.2 0.2
Allergic Rhinitis (Hay Fever) 0.3 0.4 -0.33
Allergies 1.4 0.3 3.67
Allergy to milk products 0.3 0.5 -0.67
Alopecia (Hair Loss) 0.1 -0.1
Alzheimer's disease 1.4 2.9 -1.07
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.5 0.2 1.5
Ankylosing spondylitis 0.6 0.1 5
Anorexia Nervosa 0.8 -0.8
Antiphospholipid syndrome (APS) 0.3 0.2 0.5
Asthma 0.7 0.1 6
Atherosclerosis 0.7 0.7 0
Atrial fibrillation 0.5 1.2 -1.4
Autism 2.5 2.6 -0.04
Autoimmune Disease 0.1 0.1
Barrett esophagus cancer 0 0
benign prostatic hyperplasia 0.1 0.1 0
Biofilm 0.3 0.3
Bipolar Disorder 0.4 0.4
Brain Trauma 0.1 0.1 0
Breast Cancer 0.3 0.3
Cancer (General) 0.3 0.3
Carcinoma 0.7 0.3 1.33
Celiac Disease 1.4 0.5 1.8
Cerebral Palsy 0.1 0.1 0
Chronic Fatigue Syndrome 0.6 3.9 -5.5
Chronic Kidney Disease 1.1 1.8 -0.64
Chronic Lyme 0.1 -0.1
Chronic Obstructive Pulmonary Disease (COPD) 0.2 0 0
Chronic Urticaria (Hives) 0.3 0.3 0
Coagulation / Micro clot triggering bacteria 0.3 0.3
Cognitive Function 0.1 0.3 -2
Colorectal Cancer 2.4 1.2 1
Constipation 0.8 0.8
Coronary artery disease 0.9 1.4 -0.56
COVID-19 2.1 4.4 -1.1
Crohn's Disease 1.9 1.5 0.27
Cushing's Syndrome (hypercortisolism) 0.7 -0.7
cystic fibrosis 0.3 0.1 2
d-lactic acidosis (one form of brain fog) 0.2 0.2
deep vein thrombosis 0.5 0.1 4
Denture Wearers Oral Shifts 0.2 0.2
Depression 2.2 1.7 0.29
Eczema 0.1 0.2 -1
Endometriosis 0.4 0.5 -0.25
Eosinophilic Esophagitis 0 0
Epilepsy 0.8 0.1 7
erectile dysfunction 0.2 0.2
Fibromyalgia 0.5 -0.5
Functional constipation / chronic idiopathic constipation 1.5 1 0.5
gallstone disease (gsd) 0.5 0 0
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.8 0.8 0
Generalized anxiety disorder 0.4 0.1 3
Gout 0.1 0.1
Graves' disease 0.1 0.2 -1
Gulf War Syndrome 0.2 -0.2
Halitosis 0.1 0.1
Hashimoto's thyroiditis 1.1 0.9 0.22
Heart Failure 0.4 0.9 -1.25
hemorrhagic stroke 0 0
Hidradenitis Suppurativa 0.3 0.3
High Histamine/low DAO 0.2 0.2
hypercholesterolemia (High Cholesterol) 0.5 0.5
hyperglycemia 0.3 0.1 2
Hyperlipidemia (High Blood Fats) 0.2 0.2
hypersomnia 0.2 -0.2
hypertension (High Blood Pressure 0.8 0.8 0
Hypoxia 0.1 0.1
IgA nephropathy (IgAN) 0.1 0.5 -4
Inflammatory Bowel Disease 1.6 3.3 -1.06
Insomnia 0.3 0.4 -0.33
Intelligence 0.4 0.2 1
Intracranial aneurysms 0.1 0.1
Irritable Bowel Syndrome 1.2 0.7 0.71
ischemic stroke 0.3 0.5 -0.67
Liver Cirrhosis 1.5 0.5 2
Long COVID 2.2 1.6 0.38
Low bone mineral density 0.3 -0.3
Lung Cancer 0.3 0.2 0.5
Lymphoma 0.1 0.1
Mast Cell Issues / mastitis 0.2 0.2
ME/CFS with IBS 0.2 1.6 -7
ME/CFS without IBS 0.3 0.6 -1
Menopause 0.2 0.2
Metabolic Syndrome 1.7 1.7 0
Mood Disorders 1.6 1.2 0.33
Multiple Sclerosis 0.9 1.7 -0.89
Multiple system atrophy (MSA) 0.1 0.1
myasthenia gravis 0.1 0.1
neuropathic pain 0.7 -0.7
Neuropathy (all types) 0.6 -0.6
neuropsychiatric disorders (PANDAS, PANS) 0.5 0.5
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 1.1 1.3 -0.18
NonCeliac Gluten Sensitivity 0.1 0.1 0
Obesity 2.9 1.2 1.42
obsessive-compulsive disorder 2 1.4 0.43
Osteoarthritis 0.7 0.3 1.33
Osteoporosis 0.2 0.1 1
pancreatic cancer 0.3 0.3
Parkinson's Disease 2.8 2.3 0.22
Polycystic ovary syndrome 1.2 0.5 1.4
primary biliary cholangitis 0.1 -0.1
Primary sclerosing cholangitis 0.1 0.7 -6
Psoriasis 0.7 0.8 -0.14
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1 1.1 -0.1
Rosacea 0.6 0.6
Schizophrenia 0.9 0.1 8
scoliosis 0.4 0.2 1
sensorineural hearing loss 0.4 0.4
Sjögren syndrome 0.6 0.4 0.5
Sleep Apnea 0 0.1 0
Slow gastric motility / Gastroparesis 0.3 0.3
Small Intestinal Bacterial Overgrowth (SIBO) 0.3 0.3
Stress / posttraumatic stress disorder 0.3 0.1 2
Systemic Lupus Erythematosus 0.8 0.4 1
Tic Disorder 0.9 0.5 0.8
Tourette syndrome 0.1 -0.1
Type 1 Diabetes 1.2 0.9 0.33
Type 2 Diabetes 3 1.1 1.73
Ulcerative colitis 1.3 2 -0.54
Unhealthy Ageing 1.9 1 0.9
Vitiligo 0.2 0.3 -0.5

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]